Clinical trial

Comparison of Glycemic Control Achieved With 2 Different Needles

NCT00572052

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-12-01

PhasePHASE4

Study timeline

Study start (unknown)2002-12-01Date precision: month

Registry last updated2017-01-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetesunresolved

Diabetes Mellitus, Type 1unresolved

Diabetes Mellitus, Type 2unresolved

Delivery Systemsunresolved

Interventions

NovoFine® needle 6 mmDEVICE

Ultra-Fine needle 12.7 mmDEVICE

Sponsors & collaborators

Novo Nordisk A/Slead sponsor

Mapped research locations

San AntonioTexas, United States1 Walnut CreekCalifornia, United States1 KetteringOhio, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00572052 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.